A phase I/IIa study to evaluate the safety, pharmacokinetics and pharmacodynamics of Macuneos in healthy volunteers and then in patients suffering from dry AMD.

Trial Profile

A phase I/IIa study to evaluate the safety, pharmacokinetics and pharmacodynamics of Macuneos in healthy volunteers and then in patients suffering from dry AMD.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Macuneos (Primary)
  • Indications Dry age-related macular degeneration
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Acronyms MACA-PK
  • Most Recent Events

    • 22 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top